Bevacizumab Injection 400 mg/16 mL – Trusted Targeted Therapy Exporter from India

Bevacizumab Injection 400 mg/16 mL is an important targeted oncology medicine used in the management of several advanced cancers under specialist supervision. Hospitals, oncology distributors, and pharmaceutical importers require dependable suppliers capable of delivering quality-assured biologic medicines with complete export support. Ernest Impex supplies export-quality Bevacizumab Injection manufactured through WHO-GMP-compliant facilities, offering secure packaging, international documentation, and efficient global logistics. Our commitment to quality and reliable delivery makes us a preferred pharmaceutical export partner for licensed healthcare buyers worldwide.Medical Uses

Bevacizumab injection may be prescribed by oncology specialists as part of combination therapy for selected cancers, including:

• Metastatic colorectal cancer
• Non-small cell lung cancer (NSCLC)
• Glioblastoma
• Advanced renal cell carcinoma
• Cervical cancer
• Ovarian, fallopian tube, and primary peritoneal cancers (in appropriate treatment settings)

The choice of treatment depends on the patient's diagnosis, overall health, and the oncologist's clinical assessment.

Precautions

• Patients should undergo a complete medical evaluation before starting treatment.
• Blood pressure should be monitored regularly due to the risk of hypertension.
• Kidney function should be assessed periodically during therapy.
• Patients with a history of bleeding disorders or blood clots should inform their healthcare provider.
• Wound healing status should be evaluated, as the medicine may affect healing.
• The injection must be administered only by trained healthcare professionals.
• Patients should immediately report symptoms such as severe bleeding, chest pain, persistent headache, abdominal pain, or shortness of breath.